Guardant Health Inc - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GH Nasdaq 2835 http://www.guardanthealth.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Guardant Health Inc

Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe - Jan 18th, 2021 8:00 am
Guardant Health to Present Data at ASCO Gastrointestinal Cancers Symposium Showing Value of Liquid Biopsy to Advance Precision Oncology in Early to Late-Stage Colorectal Cancer - Jan 14th, 2021 1:05 pm
The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations - Jan 13th, 2021 12:25 pm
12 Best Telemedicine Stocks to Buy Now - Jan 7th, 2021 6:18 pm
What Type Of Shareholders Make Up Guardant Health, Inc.'s (NASDAQ:GH) Share Registry? - Jan 6th, 2021 7:47 am
Guardant Health to Participate in the 39th Annual J.P. Morgan Healthcare Conference - Dec 30th, 2020 9:03 pm
The 3 Best Healthcare Stocks to Buy for 2021 - Dec 27th, 2020 12:31 pm
Stocks This Hot Goldman Sachs Fund Likes Besides Amazon, Apple, Netflix - Dec 24th, 2020 3:21 pm
3 High-Growth Stocks That'll Make You Richer in 2021 and Beyond - Dec 18th, 2020 11:04 am
Is GH A Good Stock To Buy Now? - Dec 15th, 2020 7:35 pm
Guardant Health Names Michael Bell as New Chief Financial Officer - Dec 11th, 2020 10:00 pm
Is Guardant Health (GH) a Smart Long-term Buy? - Dec 8th, 2020 5:32 pm
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings - Dec 8th, 2020 1:03 pm
Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World Platform in Metastatic Breast Cancer - Dec 7th, 2020 1:05 pm
Got $3,000? 3 Growth Stocks to Buy That Could Skyrocket - Nov 27th, 2020 11:09 am
Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering - Nov 17th, 2020 4:22 am
Why Guardant Health Tumbled by Over 10% on Monday - Nov 16th, 2020 11:45 pm
Guardant Health, Inc. Announces Proposed Convertible Senior Notes Offering - Nov 16th, 2020 11:47 am
Wild Ride For Illumina Stock Shows Promise, Challenge Of Multi-Cancer Blood Tests - Nov 13th, 2020 1:30 pm
Here's What Analysts Are Forecasting For Guardant Health, Inc. (NASDAQ:GH) After Its Third-Quarter Results - Nov 7th, 2020 2:43 pm